Skip to main content
Article
The presence of S-sulfonated transthyretin in commercial human serum albumin solutions: Potential contribution to neuropathy
Clinica Chimica Acta (2019)
  • Leonard T. Rael, Research Medical Center
  • Raphael Bar-Or, Research Medical Center
  • Kaysie L. Banton, Rocky Vista University College of Osteopathic Medicine
  • Charles W. Mains, Rocky Vista University College of Osteopathic Medicine
  • Robert M. Madayag, St. Anthony Hospital, Lakewood, CO, United States of America.
  • Gary T. Marshall, Medical City Plano, Plano, TX, United States of America.
  • I.I. Allen Tanner, University of Colorado Colorado Springs
  • Michael Waxman, Research Medical Center
  • David L. Acuna, Wesley Medical Center
  • David Bar-Or, Swedish Medical Center, Englewood, CO, United States of America
Disciplines
Publication Date
December 1, 2019
DOI
10.1016/J.CCA.2019.08.034
Citation Information
Leonard T. Rael, Raphael Bar-Or, Kaysie L. Banton, Charles W. Mains, et al.. "The presence of S-sulfonated transthyretin in commercial human serum albumin solutions: Potential contribution to neuropathy" Clinica Chimica Acta Vol. 499 (2019) p. 70 - 74
Available at: http://works.bepress.com/kaysie-banton/16/